NEPHROS INC
NEPH · XNASCIK 1196298fmd_1G02AN3XW6YN90RANATSN20XYAManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 02, 2009 to Sep 30, 2026, 67 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 2 | 4 | 6 | 10 | 9 | 10 | 10 | 14 | 14 | 19 |
| Cost of revenue | 1 | 2 | 2 | 4 | 4 | 5 | 5 | 6 | 5 | 7 |
| Gross profit | 1 | 2 | 3 | 6 | 5 | 6 | 5 | 8 | 9 | 12 |
| Research and development | 1 | 1 | 2 | 3 | 3 | 1 | 1 | 1 | 1 | 1 |
| Selling, general and administrative | 3 | 3 | 5 | 6 | 6 | 7 | 8 | 9 | 8 | 9 |
| Total operating expenses | 4 | 5 | 6 | 9 | 9 | 9 | 9 | 10 | 9 | 10 |
| Operating income | (3) | (2) | (3) | (3) | (4) | (3) | (4) | (2) | 0 | 1 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest and investment income | 0 | 0 | 0 | – | – | – | – | – | – | – |
| Other non-operating income (expense) | 0 | (0) | (0) | (0) | (0) | 0 | 0 | 0 | 0 | 0 |
| Income before taxes | (3) | (3) | (3) | (3) | (5) | – | – | (2) | 0 | 1 |
| Income tax expense | – | (2) | (0) | (0) | – | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | – | (1) | (3) | (3) | – | (3) | (4) | (2) | 0 | 1 |
| Net income | (3) | (1) | (3) | (3) | (5) | (4) | (7) | (2) | 0 | 1 |
| Net income to common shareholders | (3) | – | – | (3) | (5) | (4) | (7) | (2) | – | – |